SEC Form D · filed May 10, 2021
Triumvira Immunologics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Brian M. Bloom · AUSTIN, TXDirectorPaul Lammers, Md, Msc · AUSTIN, TXExec · DirectorCynthia M. Collins, Mba · AUSTIN, TXDirectorTeresa C. Mcroberts · AUSTIN, TXExecScott M. Smith · AUSTIN, TXDirectorShaan C. Gandhi, Md, Dphil · AUSTIN, TXDirectorElizabeth C. Williams · AUSTIN, TXDirectorJon C. Irvin · AUSTIN, TXExecLee M. Cooper · AUSTIN, TXDirectorJurgen M. Eckhardt · AUSTIN, TXDirectorRobert F. Bierig · Chicago, ILExecJacob Bond · Vancouver, WADirectorGregory R. Piefer · JANESVILLE, WIDirectorNatalie Levy · Boulder, CODirectorGregory D. Smith · JANESVILLE, WIDirectorJeremy Burger · Seattle, WADirectorEric G. Schutt · JANESVILLE, WIDirectorAndrew Cunningham · Washington, Washington, D.C.ExecDavid A. Newberg · JANESVILLE, WIExec · DirectorDennis Tilley · Seattle, WADirectorVernon D. Gair Jr · Chicago, ILDirectorAndrea K. Jackson · Madison, WIDirectorSteven K. Galson · Madison, WIExec · DirectorManeesh K. Arora · Madison, WIDirectorTerrence K. Brady · Madison, WIDirectorPaul K. Berns · Madison, WIDirectorBrandon Arvanaghi · Miami Beach, FLDirectorDanting Wang · Grand Cayman, Cayman IslandsExecYiran Liu · Grand Cayman, Cayman IslandsExecDanting Wang · Grand Cayman, Cayman IslandsDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗